Related Experiment Video
Updated: Oct 7, 2025
09:40
Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
Published on: October 4, 2019
5.8K
m6A Regulator Expression Segregates Meningiomas Into Biologically Distinct Subtypes.
Jiawei Chen1,2,3, Shuchen Sun1,2,3, Leihao Ren1,2,3
1Department of Neurosurgery, Huashan Hospital, Fudan University, Shanghai, China.
Frontiers in Oncology
|January 10, 2022
Summary
m6A regulator gene expression may serve as a novel prognostic marker for meningioma, a common brain tumor. This study identified distinct molecular subtypes based on these regulators, offering new insights into meningioma classification and patient outcomes.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Meningiomas are the most common primary intracranial tumors in adults, with varying grades of malignancy.
- Dysregulation of N6-methylation (m6A) regulators is implicated in various human cancers.
- Understanding meningioma molecular characteristics is crucial for improved diagnostics and therapeutics.
Purpose of the Study:
- To investigate the association between m6A regulator expression and meningioma molecular subtypes.
- To explore the correlation between m6A regulators and immune infiltration in meningiomas.
- To identify potential novel prognostic markers for meningioma.
Main Methods:
- Analysis of m6A modification patterns in 160 meningioma samples using 19 m6A regulators.
- Correlation of m6A regulator expression with immune infiltration characteristics.
- Definition of novel molecular subtypes based on prognostic hub gene expression.
Main Results:
- Two distinct meningioma clusters were identified based on m6A regulator expression.
- Significant differentially expressed genes (DEGs) were found, with specific modules linked to cancer-related pathways like Wnt signaling.
- Three potential marker genes (EPN1, EXOSC4, H2AX, MZT2B) were identified for specific meningioma subtypes.
Conclusions:
- m6A regulator gene expression represents a potential novel prognostic marker for meningioma.
- The identified molecular subtypes based on m6A regulators may aid in personalized treatment strategies.
- Further research into m6A regulators could enhance meningioma classification and patient management.
Related Concept Videos
02:23Master Transcription Regulators
7.2K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.2K
01:37Neural Regulation
40.5K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
40.5K